Management of Fatty Liver with Elevated Liver Enzymes
Initial Diagnostic Workup
- The American College of Radiology recommends calculating the AST:ALT ratio to differentiate between alcoholic and non-alcoholic causes of fatty liver, with a ratio >2 suggesting alcohol-induced liver disease and a ratio <1 indicating metabolic disease-related NAFLD 1, 2
- Quantify alcohol consumption through detailed clinical evaluation, as excessive alcohol intake (>20-30 g/day) defines alcoholic liver disease 4
- Exclude other common causes of elevated liver enzymes, including viral hepatitis, drug-induced liver injury, hereditary hemochromatosis, autoimmune hepatitis, alpha1-antitrypsin deficiency, and Wilson disease 1, 2
- Document body mass index and waist circumference, as NAFLD prevalence increases with obesity and diabetes mellitus 1, 2
- Check blood pressure as part of comprehensive metabolic syndrome evaluation 5
Risk Stratification for Disease Severity
- Calculate FIB-4 or NAFLD Fibrosis Score for non-invasive fibrosis risk stratification, as enzyme levels alone do not predict fibrosis stage 3, 5
- Recognize that 25-30% of NAFLD cases progress to NASH with hepatocyte injury and inflammation, which can lead to fibrosis, cirrhosis, and hepatocellular carcinoma 1, 2, 3
Treatment Strategy
- Prescribe weight loss of 7-10% body weight through caloric restriction and exercise as the primary treatment for NAFLD 5
- Restrict saturated fat to <7% of total calories as part of dietary intervention 5
- Statins are not contraindicated and may be beneficial for cardiovascular risk reduction in NAFLD patients 5
Monitoring and Follow-Up
- Repeat liver enzymes in 2-3 months to establish trend, as 84% of abnormal liver tests remain abnormal at 1 month and 75% at 2 years 5
- Refer immediately if ALT >8× upper limit of normal (ULN) or >5× baseline, or if ALT >3× ULN with total bilirubin >2× ULN, or if evidence of synthetic dysfunction 5